Covalent Anchoring of Enzyme‐Activatable Fluorescent Signals for in Situ Imaging and Longitudinal Staging of Cellular Senescence in Pulmonary Fibrosis
Small · 2026-10 · 22 (58)
DOI: 10.1002/smll.75215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 11.08.2026. Verfasst von Feiyi Chu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, People's Republic of China. Hauptthemen laut MEDLINE: Cellular Senescence, Pulmonary Fibrosis, Fluorescent Dyes. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Hunan Province.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease caused by the pathological accumulation of senescent cells. In this fibrotic microenvironment, senescence‐associated β‐galactosidase (SA‐β‐Gal) serves as a key biomarker. However, existing SA‐β‐Gal molecular probes suffer from signal diffusion and rapid clearance due to the extracellular leakage, compromising imaging fidelity. To address this issue, an enzyme‐activated covalent labelling strategy is proposed, and as a design paradigm developing TCFM‐Gal , a imaging tool integrating β‐galactosidic fluorophore with an ortho‐difluoromethyl leaving group. Upon SA‐β‐Gal‐mediated hydrolysis, TCFM‐Gal generates a quinone methide intermediate that covalently anchors to surrounding nucleophiles, confining fluorescence within lysosomes. In senescent cells, TCFM‐Gal achieves extended lysosome‐retained imaging, maintaining over 85% signal retention within 24 h. In the IPF model, TCFM‐Gal enables longitudinal tracking of senescent cells and maintains a high signal intensity after 24 h. Rapid circulatory washout and high interstitial fluid pressure make conventional probes ineffective in the lungs. TCFM‐Gal overcomes this not just by sensing, but by anchoring the signals in situ. Moreover, TCFM‐Gal facilitates staging assessments of fibrosis progression by quantifying the senescence burden across disease phases. This study establishes an enzyme‐activated covalent labeling paradigm for high‐fidelity senescence imaging, advancing the spatiotemporal mapping of senescence in lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, People's Republic of China.
- Department of Pharmacy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, People's Republic of China.
- Department of Oncology and Institute of Medical Sciences, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410078, People's Republic of China.
- Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410078, People's Republic of China.
ORCID-Profile: Xueping Feng, Jie Dong, Fei Chen, Wenbin Zeng
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Hunan Province
Zitieren
APA
Chu, F., Feng, B., Tian, H., Zhou, J., Li, C., Zhu, Y., Zhou, J., Feng, X., Dong, J., Chen, F., & Zeng, W. (2026). Covalent Anchoring of Enzyme‐Activatable Fluorescent Signals for in Situ Imaging and Longitudinal Staging of Cellular Senescence in Pulmonary Fibrosis. Small, 22(58). https://doi.org/10.1002/smll.75215
Vancouver
Chu F, Feng B, Tian H, Zhou J, Li C, Zhu Y, et al. Covalent Anchoring of Enzyme‐Activatable Fluorescent Signals for in Situ Imaging and Longitudinal Staging of Cellular Senescence in Pulmonary Fibrosis. Small. 2026;22(58). doi:10.1002/smll.75215
BibTeX
@article{Chu2026,
author = {Chu, Feiyi and Feng, Bin and Tian, Huanfeng and Zhou, Jin and Li, Chengmin and Zhu, Yingli and Zhou, Jing and Feng, Xueping and Dong, Jie and Chen, Fei and Zeng, Wenbin},
title = {Covalent Anchoring of Enzyme‐Activatable Fluorescent Signals for in Situ Imaging and Longitudinal Staging of Cellular Senescence in Pulmonary Fibrosis},
journal = {Small},
year = {2026},
volume = {22},
number = {58},
doi = {10.1002/smll.75215}
}
EUVIMED